Spontaneous regression of human cancer cells in vitro: Potential role of disruption of Cdk1/Cdk4 co-expression

Anticancer Research

Volumn 29, Issue 6, 2009, Pages 1933-1941

  Warenius, Hilmar ^a,b   Kyritsi, Leto ^c   Grierson, I A N ^d   Howarth, Amanda ^e   Seabra, Laurence ^f   Jones, Mark ^g   Thomas, Carole ^d   Browning, Paul ^h   White, Rosalind ⁱ  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b HilRoS Ltd   (United Kingdom)

^c UNIVERSITY OF THE AEGEAN   (Greece)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e Theryte Ltd   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g Centre for Stem Cell Biology   (United Kingdom)

^h NATIONAL HEALTH SERVICE   (United Kingdom)

ⁱ Westering   (United Kingdom)

Author keywords

Cdk1; Cdk4; Cell loss; Clonogenic assays; Spontaneous regression; Starbursts

Indexed keywords

CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4;

ADHERENT CELL; ARTICLE; BLADDER CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CANCER REGRESSION; CELL DEATH; CELL LOSS; CLONOGENIC ASSAY; COLON ADENOCARCINOMA; COLONY FORMATION; CONTINUOUS CULTURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LARGE CELL CARCINOMA; LARYNX CARCINOMA; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG SMALL CELL CANCER; MOUTH CARCINOMA; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM CARCINOMA; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, LARGE CELL; CDC2 PROTEIN KINASE; CELL SURVIVAL; COLONY-FORMING UNITS ASSAY; CYCLIN-DEPENDENT KINASE 4; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; NEOPLASM REGRESSION, SPONTANEOUS; SKIN; TUMOR CELLS, CULTURED;

EID: 67650889130     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Steel GG: Cell loss from experimental tumours. Cell Tissue Kinet 1: 193-207, 1968.
2. Bertuzzi A, Gandolfi A, Sinisgalli C, Starce G and Ubezio P: Cell loss and the concept of potential doubling time. Cytometry 29: 34-40, 1997. (Pubitemid 27397795)
3. Kerr J, Winterford C and Harmon B: Apoptosis. Its significance in cancer and cancer therapy. Cancer 73: 2013-2023, 1994.
4. Elston D: Mechanisms of regression. Clin Med Res 2: 85-88, 2004.
5. Smyth M and Kershaw M: Discovery of an innate cancer resistance gene. Mol Intervent 3: 186-189, 2003.
6. Abdelrazeq A: Spontaneous regression of colorectal cancer: a review of cases from 1900-2005. Int J Colorectal Dis 22: 727-736, 2007.
7. Chang W: Complete spontaneous regression of cancer: Four case reports, review of literature and discussion of possible mechanisms involved. Hawaii Med J 59: 379-387, 2000.
8. McGovern V: Spontaneous regression of melanoma. Pathology 2: 91-99, 1975.
9. Jonsson H, Johansson R and Lenner P: Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer 117: 842-847, 2005. (Pubitemid 41598838)
10. Zahl P-H and Mælen J: Do model results suggest spontaneous regression of breast cancer? Int J Cancer 118: 2647-2649, 2006.
11. Seabra L and Warenius H: Proteomic co-expression of cyclin-dependent kinases 1 and 4 in human cancer cells. Eur J Canc 43: 1483-1492, 2007. (Pubitemid 46874066)
12. Warenius H, Seabra L, Kyritsi L et al: Theranostic proteomic profiling of cyclins, cyclin dependent kinases and ras in human cancer cell lines is dependent on p53 mutational status. Int J Oncology 32: 895-907, 2008. (Pubitemid 351780600)
13. Wurm R, Burnet N, Duggal N, Yarnold J and Peacock J: Cellular radiosensitivity and DNA damage in primary human fibroblasts. Int J Radiat Oncol Biol Phys 30: 625-633, 1994. (Pubitemid 24304474)
14. Rudat V, Dietz A, Conradt C, Weber K-J and Flentje M: In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer. Radiother Oncol 43: 181-188, 1997.
15. Begg A, McNally N, Shrieve D and Kärcher H: A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6: 620-626, 1985. (Pubitemid 16257694)
16. Araujo R, Liotta L and Petricoin E: Proteins, drug targets and the mechanisms they control: the simple truth about complex networks. Nature Rev Drug Discovery 6: 871-880, 2007. (Pubitemid 350042395)
17. Tenen D: Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer 3: 89-101, 2003. (Pubitemid 37328876)
18. Kerr J, Wyllie A and Currie A: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
19. Breivik J: The evolutionary origin of genetic instability in cancer development. Semin Can Biology 15: 51-60, 2005. (Pubitemid 40018528)
20. Tomlinson I, Novelli M and Bodmer W: The mutation rate and cancer. Proc Natl Acad Sci USA 93: 14800-14803, 1996.
21. Hanahan D and Weinberg R: The hallmarks of cancer. Cell 100: 57-70, 2000.
22. Weinstein B: Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. Carcinogenesis 21: 857-864, 2000.
23. Warenius H: Are critical normal gene products in cancer cells the real therapeutic targets? Anticancer Res 22: 2651-2656, 2002.
24. Warenius H, Howarth A, Seabra L, Kyritsi L, Dormer R, Irwin S and Thomas C: Dynamic heterogeneity of proteomic expression in human cancer cells does not affect Cdk1/Cdk4 co-expression. J Exp Ther Oncol 7: 237-254, 2008.